#Hengrui Pharma

Last 24h 📈 Bullish 📈2

Last 7 Days 📈 Bullish 📈2

Last 30 Days 📈 Bullish 📈2

Release 📈 Stocks

Hengrui Pharma Secures 64 ESMO 2026 Abstracts to Bolster Oncology Pipeline

October 21, 2026 (just now)

Hengrui Pharma strengthens its oncology portfolio as 64 abstracts, including key proffered papers on HER2 and HER3 antibody-drug conjugates, are accepted for…

600276.SS

🌍 ASIA Read More →

Release 📈 Stocks

Hengrui Pharma Shares 64 Research Findings at ESMO 2026 Oncology Conference

October 21, 2026 (just now)

Hengrui Pharma secures 64 research presentations at ESMO 2026, showcasing significant progress in its oncology pipeline with a focus on HER2- and…

600276.SS

🌍 ASIA Read More →